D50 (radiotherapy): Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 36: | Line 36: | ||
{{No image}} | {{No image}} | ||
{{No image}} | {{No image}} | ||
__NOINDEX__ | |||
Latest revision as of 08:16, 17 March 2025
D50 (Radiotherapy)
The D50 is a term used in radiotherapy, a form of cancer treatment that uses high doses of radiation to kill cancer cells and shrink tumors. The D50 is a measure of the dose of radiation that will cause a 50% reduction in the volume of a tumor.
Definition[edit]
In radiotherapy, the D50 is defined as the dose of radiation that will cause a 50% reduction in the volume of a tumor. This is a measure of the effectiveness of the treatment, as it indicates the amount of radiation needed to significantly reduce the size of the tumor.
Calculation[edit]
The D50 is calculated using the tumor volume before and after treatment. The pre-treatment volume is compared to the post-treatment volume, and the dose of radiation that resulted in a 50% reduction is the D50.
Use in Treatment Planning[edit]
The D50 is used in treatment planning to determine the optimal dose of radiation to deliver to a tumor. By knowing the D50, clinicians can tailor the treatment to the individual patient, ensuring that the tumor is effectively treated while minimizing damage to surrounding healthy tissue.
Limitations[edit]
While the D50 is a useful measure of treatment effectiveness, it has limitations. It assumes that the tumor is a uniform mass, which is often not the case. Tumors can have areas of varying sensitivity to radiation, which can affect the D50. Additionally, the D50 does not take into account the potential for tumor regrowth after treatment.
See Also[edit]
References[edit]
<references />


